Yanfeng Sunflower No. 1 Private Equity Securities Investment Fund managed by Shanghai Yanfeng Investment Management Co., Ltd signed a share transfer agreement to acquire 5% stake in Thalys Medical Technology Group Inc. (SHSE:603716) from Saihai (Shanghai) Health Technology Co., Ltd. for CNY 140 million on November 4, 2021. As per terms, 10,251,050 shares will be acquired for CNY 13.63 per share. The consideration shall be paid within 30 working days after transfer confirmation. Post completion, Saihai (Shanghai) Health Technology Co., Ltd stake will reduce from 37.18% to 32.18%.